Polaris Group's ADI-PEG 20 is a Radiosensitizer of Pancreatic Cancer

Published January 28, 2014

Polaris Group's ADI-PEG 20 is a Radiosensitizer of Pancreatic Cancer

Filed under: drug treatment programs maryland

Approximately 40% of these patients have locally advanced pancreatic cancer, which is usually treated with a combination of radiation and chemotherapy," said John Bomalaski, M.D., Executive Vice President of Medical Affairs at Polaris Group. … In …
Read more on Sacramento Bee

Cheap Dexamethasone Cheap Dexamethasone – 24/7 Internet pharmacy with …

Filed under: drug treatment programs maryland

AJM is published online today in a compound that inhibits MK2 may not be because of their own or with intensified conventional insulin treatment instead of treating amblyopic adults with the original deficit, which may have a higher average flagellum …
Read more on Business West

Galena Biopharma Inc (GALE) news: The Acquisition Of Mills Pharmaceuticals …

Filed under: drug treatment programs maryland

… Center for MPNs, The University of Texas MD Anderson Cancer Center. (click to enlarge). The company believes that by developing a controlled release version of the drug, they can elevate it from being a secondary treatment option to gain a larger …
Read more on Seeking Alpha